Lyell Immunopharma (LYEL) Selling, General & Administrative (2020 - 2026)
Lyell Immunopharma (LYEL) posted Selling, General & Administrative of $9.58 million for Q2 2026, down 2.1% from $9.79 million a year earlier but up 0.2% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Selling, General & Administrative (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Lyell Immunopharma was $40.43 million, down 19.3% year-over-year; for FY2025, it came in at $45.14 million, down 13.3% from FY2024.
- Annual Selling, General & Administrative has declined for three consecutive years, with a five-year compound annual growth rate of -0.8% (FY2020 to FY2025).
- In prior years, Lyell Immunopharma's Selling, General & Administrative was $52.04 million in FY2024 (-22.3%), $66.98 million in FY2023 (-42.9%), $117.31 million in FY2022 (+31.7%) and $89.06 million in FY2021 (+90.0%).
- Quarterly Selling, General & Administrative has run from a low of $9.56 million in Q1 2026 to a high of $34.42 million in Q1 2022 over five years.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last five quarters, with an average decline of 12.5% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 114.4%; the weakest was Q4 2023, with a decline of 50.0%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $9.56 million (Q1 2026), $10.62 million (Q4 2025) and $10.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Lyell Immunopharma | 216.66 Mn | 216.66 Mn | - | 9.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.58 Mn |
| Mar 31, 2026 | 9.56 Mn |
| Dec 31, 2025 | 10.62 Mn |
| Sep 30, 2025 | 10.69 Mn |
| Jun 30, 2025 | 9.79 Mn |
| Mar 31, 2025 | 14.05 Mn |
| Dec 31, 2024 | 14.52 Mn |
| Sep 30, 2024 | 11.77 Mn |
| Jun 30, 2024 | 12.26 Mn |
| Mar 31, 2024 | 13.49 Mn |
| Dec 31, 2023 | 13.17 Mn |
| Sep 30, 2023 | 15.51 Mn |
| Jun 30, 2023 | 19.03 Mn |
| Mar 31, 2023 | 19.28 Mn |
| Dec 31, 2022 | 26.35 Mn |
| Sep 30, 2022 | 26.08 Mn |
| Jun 30, 2022 | 30.45 Mn |
| Mar 31, 2022 | 34.42 Mn |
| Dec 31, 2021 | 31.87 Mn |
| Sep 30, 2021 | 21.24 Mn |
API Access
Lyell Immunopharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();